Cilastatin

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Cilastatin
Cilastatin.svg
Cilastatin ball-and-stick.png
Clinical data
AHFS/Drugs.comInternational Drug Names
MedlinePlusa686013
Routes of
administration
IV
ATC code
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.072.592 Edit this at Wikidata
Chemical and physical data
FormulaC16H26N2O5S
Molar mass358.454 g/mol g·mol−1
3D model (JSmol)
  (verify)

Cilastatin inhibits the human enzyme dehydropeptidase.[1]

Uses[edit]

Dehydropeptidase is an enzyme found in the kidney and is responsible for degrading the antibiotic imipenem. Cilastatin can therefore be combined intravenously with imipenem in order to protect it from degradation, prolonging its antibacterial effect.

Imipenem alone is an effective antibiotic and can be given without cilastatin. Cilastatin itself does not have antibiotic activity, although it has been proved to be active against a zinc-dependent beta-lactamase that usually confers antibiotic resistance to certain bacteria, more precisely, the carbapenem family of antibiotics; this property is due to the physicochemical similarities between membrane dipeptidase (MDP), the compound it is usually set to target, and the bacterial metallo-beta-lactamase carried by the CphA gene.[1] The combination allows the antibiotic to be more effective by changing the pharmacokinetics involved, thus imipenem/cilastatin, like amoxicillin/clavulanic acid, is a commonly used combination product.

References[edit]

  1. ^ a b Keynan S, Hooper NM, Felici A, Amicosante G, Turner AJ (1995). "The renal membrane dipeptidase (dehydropeptidase I) inhibitor, cilastatin, inhibits the bacterial metallo-beta-lactamase enzyme CphA". Antimicrob. Agents Chemother. 39 (7): 1629–31. doi:10.1128/aac.39.7.1629. PMC 162797. PMID 7492120.